Guanosine 5'-Pyrophosphate Ester 6-Deoxytalose
![]() |
- $350 - $4250
- Product name: Guanosine 5'-Pyrophosphate Ester 6-Deoxytalose
- CAS: 18657-20-0
- MF: C16H25N5O15P2
- MW: 589.34
- EINECS:
- MDL Number:
- Synonyms:Guanosine 5'-Pyrophosphate Ester 6-Deoxytalose;Guanosine 5'-Pyrophosphate Ester 6-Deoxytalose (>90%) DisodiuM Salt;Guanosine 5'-(trihydrogen diphosphate), P'-(6-deoxy-α-D-talopyranosyl) ester;Guanosine 5′-Pyrophosphate Ester 6-Deoxytalose Disodium Salt
3 prices
Selected condition:
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 0.25mg
- 2.5mg
- ManufacturerMedical Isotopes, Inc.
- Product number58478
- Product descriptionGuanosine 5??-Pyrophosphate Ester 6-Deoxytalose (>90%) Disodium Salt
- Packaging0.25mg
- Price$850
- Updated2021-12-16
- Buy
- ManufacturerMedical Isotopes, Inc.
- Product number58478
- Product descriptionGuanosine 5??-Pyrophosphate Ester 6-Deoxytalose (>90%) Disodium Salt
- Packaging2.5mg
- Price$4250
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberG838600
- Product descriptionGuanosine5''-PyrophosphateEster6-Deoxytalose(>90%)DisodiumSalt
- Packaging0.25mg
- Price$350
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Medical Isotopes, Inc. | 58478 | Guanosine 5??-Pyrophosphate Ester 6-Deoxytalose (>90%) Disodium Salt | 0.25mg | $850 | 2021-12-16 | Buy |
Medical Isotopes, Inc. | 58478 | Guanosine 5??-Pyrophosphate Ester 6-Deoxytalose (>90%) Disodium Salt | 2.5mg | $4250 | 2021-12-16 | Buy |
TRC | G838600 | Guanosine5''-PyrophosphateEster6-Deoxytalose(>90%)DisodiumSalt | 0.25mg | $350 | 2021-12-16 | Buy |
Properties
Melting point :>180°C (dec.)
storage temp. :Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility :Water
form :Solid
color :White
storage temp. :Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility :Water
form :Solid
color :White
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|